Page 211 - Pharmaceutics IV (02-06-01305)

completion of product filtration .In addition ,an in-process 20 minute
endotoxin ( limit test )& a standard 60 minutes bacterial endotoxin
test each batch or quality control subbatch must be performed
prior to release for human use .

Each batch acceptable must be signed & the date approved
indicated.

Distribution of Radiopharmaceutical

Generally ,a lead -lined syringe container shipped in Department of

Transportation-approved & tested cases are used with appropriate
identifying information.

Tungsten is lighter ,which results in less weight per shipment ,& is
less hazardous than lead .

Regulation when a radiopharmaceutical is distributed from a central
nuclear pharmacy to another institution, which are :packaging ,

Labeling, shipping papers , record keeping , shipper & carrier
licensing ,& personal training.

Pharmaceutical Care Plan

1- Allergic reaction to 131 I ,the recommended daily allowance is
0.15 mg of dietary iodine /day .The total therapeutic dose given
in this situation would be 0.0008 mg of iodine .

2- 2-Potential pregnancy teratogenicity .The patient is
postmenopausal ,and no pregnancy test was ordered.

3- Patient was educated on procedure & precautions to be taken
regarding close contact with other people ,particularly children &
pregnant women ,after radionuclide therapy . Patient was also
educated about radioactive ablation therapy & had her questions
answered ,& written , informed consent was secured.

21